When is myPath test most helpful

When there is uncertainty, or even a reasonable possibility that a colleague might arrive at a different diagnosis than you, seeking some form of diagnostic support seems reasonable, whether that’s in the form of consultation, a discussion with the clinician, or an ancillary molecular test. Fifteen percent of all melanocytic lesions cause some level of diagnostic uncertainty or diagnostic disagreement among dermatopathologists.